Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Cell Signaling Feedback Loops01:07

Cell Signaling Feedback Loops

Positive and negative feedback loops are crucial for regulating biological signaling systems. These feedback loops are processes that connect output signals to their inputs.
Negative feedback loops
Most signaling systems have negative feedback loops that can perform different functions such as output limiter, and adaptation.
Output limiter
Upon receiving an input signal, the cellular response rapidly increases until a threshold is reached. Beyond this threshold, a negative feedback loop...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AMPK/p38 MAPK signaling selectively enhances HIF-induced VEGF-A165 expression under hypoxic and low-glucose conditions in HepG2 cells to promote endothelial cell proliferation and migration.

BMC cancer·2026
Same author

Invisible signals, visible dilemmas: The ethical frontiers of liquid biopsy in precision oncology.

Critical reviews in oncology/hematology·2026
Same author

RAB5C Increases Endothelial Release of VWF by Regulating Vesicle Trafficking.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

Historical review: more than two decades understanding the genetic architecture of hemostasis and thrombosis.

Journal of thrombosis and haemostasis : JTH·2025
Same author

Identification of miRNAs induced by low-dose methylmercury exposure and their roles in inflammatory responses using human aortic endothelial cells.

Environmental health and preventive medicine·2025
Same author

Functional Genomics Link REST to Endothelial Plasticity and Atherosclerosis.

Circulation research·2025

Related Experiment Video

Updated: Jun 25, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

MiR-34, SIRT1 and p53: the feedback loop.

Munekazu Yamakuchi1, Charles J Lowenstein

  • 1Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA. myamaku1@jhmi.edu

Cell Cycle (Georgetown, Tex.)
|February 18, 2009
PubMed
Summary

The tumor suppressor p53 activates miR-34a, which inhibits SIRT1. This interaction creates a feedback loop, enhancing p53

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • MicroRNAs (miRNAs) are key regulators of gene expression implicated in tumorigenesis.
  • The TP53 gene, frequently mutated in cancers, encodes p53, which induces miR-34 family members.
  • The miR-34 family's role in cell cycle, senescence, and apoptosis is established, but targets remain incompletely defined.

Purpose of the Study:

  • To investigate the functional relationship between miR-34a and SIRT1.
  • To elucidate the role of SIRT1 in miR-34a-mediated apoptosis.
  • To propose a novel feedback loop involving p53, miR-34a, and SIRT1 in cancer regulation.

Main Methods:

  • Investigated the inhibitory effect of miR-34a on SIRT1 expression.
  • Examined SIRT1's influence on p53 activity and apoptosis.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Experiment Videos

Last Updated: Jun 25, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

  • Utilized molecular biology techniques to validate the proposed feedback loop.
  • Main Results:

    • miR-34a directly inhibits SIRT1, a regulator of cellular senescence and longevity.
    • SIRT1 deacetylates and stabilizes p53, influencing p53-dependent apoptosis.
    • SIRT1 mediates miR-34a's apoptotic effects by modulating p53 activity.

    Conclusions:

    • A positive feedback loop exists where p53 induces miR-34a, which suppresses SIRT1, thereby enhancing p53 activity.
    • This regulatory circuit involving p53, miR-34a, and SIRT1 is crucial for apoptosis and may be a target for cancer therapy.